PARD (Poniard Pharmaceuticals) Net Margin %: 0.00% (As of Sep. 2011)


What is Poniard Pharmaceuticals Net Margin %?

Poniard Pharmaceuticals PARD Net Margin % is 0.00% as of Sep. 2011.

Net margin is calculated as Net Income divided by its Revenue. Poniard Pharmaceuticals's Net Income for the three months ended in Sep. 2011 was $-3.77 Mil. Poniard Pharmaceuticals's Revenue for the three months ended in Sep. 2011 was $0.00 Mil. Therefore, Poniard Pharmaceuticals's net margin for the quarter that ended in Sep. 2011 was 0.00%.

The historical rank and industry rank for Poniard Pharmaceuticals's Net Margin % or its related term are showing as below:


PARD's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

Poniard Pharmaceuticals  (OTCPK:PARD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Poniard Pharmaceuticals Net Margin % Related Terms

Poniard Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Net Margin % Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PARD vs OBMP, NSPX, ATRX: Net Margin % Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Net Margin % falls into.


Poniard Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Poniard Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2010 is calculated as

Net Margin=Net Income (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=-30.051/0
= %

Poniard Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2011 is calculated as

Net Margin=Net Income (Q: Sep. 2011 )/Revenue (Q: Sep. 2011 )
=-3.771/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Poniard Pharmaceuticals (PARD) has a Net Margin % of 0.00% as of Sep. 2011. Net margin is the ratio of total net income to net sales. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Net Margin % too high?
Poniard Pharmaceuticals' current Net Margin % is 0.00%.
How does Poniard Pharmaceuticals' Net Margin % compare to OBMP and NSPX?
Poniard Pharmaceuticals' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Net Margin % is 0.00% as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.